Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 796.25
-68.35 (-7.91%)
At close: Jan 23, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 73.39 billion as of January 23, 2026. Its market cap has increased by 14.09% in one year.
Market Cap
73.39B
Enterprise Value
90.03B
Revenue
46.85B
Ranking
n/a
PE Ratio
18.47
Stock Price
796.25
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 73.39B, an increase of 879.36%. That is a compound annual growth rate of 9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 79.69B | -3.97% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 191.94B |
| Alembic Pharmaceuticals | 150.28B |
| NATCO Pharma | 149.51B |
| Cohance Lifesciences | 145.99B |
| Alivus Life Sciences | 108.44B |
| Aarti Pharmalabs | 69.68B |
| Akums Drugs and Pharmaceuticals | 65.04B |
| Sun Pharma Advanced Research Company | 40.55B |